{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:54:15Z","timestamp":1787014455283,"version":"build-2736575974"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T00:00:00Z","timestamp":1301961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Immunoglobulin (Ig) therapy is the mainstay for treatment in the majority of primary immune deficiencies. While B cell defects are the predominant conditions in man, other diseases in which T cell dysfunction is severe also require antibody replacement. In many medical practices the phenotypic overlap between immune deficiency and symptoms of asthma leads to both missed opportunities for diagnosing immune defects and inappropriate Ig treatment of asthmatic patients with normal B cell function. As steroid therapy can lower serum IgG levels, this finding alone is an insufficient indicator for Ig replacement. In the past 3 decades, there has a gradual increase in recommended and commonly used doses of parenteral immune globulin, often based on both IgG trough levels and clinical responses. Special attention to Ig doses is needed for growing children, in cases of weight loss or gain, pregnancy and for subjects in whom more rapid consumption of Ig is likely, including febrile patients or those with gastrointestinal or lung disease. While acute bacterial infections are much less common in Ig-treated subjects, a number of reports note continued evidence of inflammatory complications. Monitoring patients over time includes, at minimum, physical examination, blood counts and chemistry screening tests and IgG trough levels, at 6\u201312-month intervals. Other monitoring tools include spirometry and at wider intervals with those with lung disease, carbon monoxide diffusion capacity and chest computed tomography scans. With careful selection of patients and adequate therapy, an improved quality of life is possible.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04390.x","type":"journal-article","created":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T09:13:38Z","timestamp":1301994818000},"page":"16-19","source":"Crossref","is-referenced-by-count":43,"title":["Key aspects for successful immunoglobulin therapy of primary immunodeficiencies"],"prefix":"10.1093","volume":"164","author":[{"given":"C","family":"Cunningham-Rundles","sequence":"first","affiliation":[{"name":"Mount Sinai School of Medicine, Department of Medicine, New York City, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,4,5]]},"reference":[{"key":"2021122708481426400_b1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clim.2009.10.003","article-title":"Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology","volume":"135","author":"Yong","year":"2010","journal-title":"Clin Immunol"},{"key":"2021122708481426400_b2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.2009.04029.x","article-title":"Intravenous immunoglobulins. Current understanding and future directions","volume":"1","author":"Jolles","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122708481426400_b3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"Primary immunodeficiencies: 2009 update","volume":"124","author":"Notarangelo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708481426400_b4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clim.2006.05.003","article-title":"Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency","volume":"120","author":"Alachkar","year":"2006","journal-title":"Clin Immunol"},{"key":"2021122708481426400_b5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0022-3476(96)70035-5","article-title":"Humoral immunity in steroid-dependent children with asthma and hypogammaglobulinemia","volume":"129","author":"Lack","year":"1996","journal-title":"J Pediatr"},{"key":"2021122708481426400_b6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"key":"2021122708481426400_b7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CMR.00001-09","article-title":"Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections","volume":"22","author":"Fried","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"2021122708481426400_b8","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708481426400_b9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"2021122708481426400_b10","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1007\/s10875-010-9400-y","article-title":"Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home","volume":"30","author":"Lucas","year":"2010","journal-title":"J Clin Immunol"},{"key":"2021122708481426400_b11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.iac.2008.07.003","article-title":"Management of primary antibody deficiency with replacement therapy: summary of guidelines","volume":"28","author":"Roifman","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"2021122708481426400_b12","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708481426400_b13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaci.2010.04.016","article-title":"Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia","volume":"126","author":"Kainulainen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708481426400_b14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10875-010-9423-4","article-title":"Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency","volume":"30","author":"Hagan","year":"2010","journal-title":"J Clin Immunol"},{"key":"2021122708481426400_b15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10875-007-9096-9","article-title":"Carimune NF liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases","volume":"27","author":"Berger","year":"2007","journal-title":"J Clin Immunol"},{"key":"2021122708481426400_b16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/ped.2010.0009","article-title":"In vivo assessment of clinically relevant autoantibodies in intravenous immunoglobulin preparations","volume":"23","author":"Abbott JACJA","year":"2010","journal-title":"Pediatr Allergy Immunol Pulmonol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04390.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/164\/Supplement_2\/16\/41909009\/j.1365-2249.2011.04390.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/164\/Supplement_2\/16\/41909009\/j.1365-2249.2011.04390.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:23:18Z","timestamp":1641036198000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/164\/Supplement_2\/16\/6438944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,5]]},"references-count":16,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2011,4,5]]},"published-print":{"date-parts":[[2011,4,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04390.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,6]]},"published":{"date-parts":[[2011,4,5]]}}}